1. Home
  2. GREE vs LEXX Comparison

GREE vs LEXX Comparison

Compare GREE & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenidge Generation Holdings Inc.

GREE

Greenidge Generation Holdings Inc.

HOLD

Current Price

$1.36

Market Cap

20.4M

Sector

Finance

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.70

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GREE
LEXX
Founded
1937
2004
Country
United States
Canada
Employees
N/A
7
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
16.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GREE
LEXX
Price
$1.36
$0.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
148.5K
132.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.46
52 Week High
$2.42
$1.90

Technical Indicators

Market Signals
Indicator
GREE
LEXX
Relative Strength Index (RSI) 51.11 47.95
Support Level $1.13 $0.58
Resistance Level $1.42 $0.87
Average True Range (ATR) 0.17 0.08
MACD 0.01 0.00
Stochastic Oscillator 30.65 38.33

Price Performance

Historical Comparison
GREE
LEXX

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: